Cellular implant therapy - MicroIslet
Alternative Names: Microencapsulated porcine islets for implantation - MicroIslet; MicroIslet-PLatest Information Update: 04 Nov 2017
At a glance
- Originator Duke University
- Developer Duke University; MicroIslet; The Scripps Research Institute; University of California, Davis
- Class Antihyperglycaemics; Mesenchymal stem cell therapies
- Mechanism of Action Cell replacements; Insulin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 1 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (Intra-abdominal, Implant)
- 03 Jul 2008 Interim pharmacodynamics & adverse events data from preclinical trials in rodents and primates with Diabetes released by MicroIslet
- 17 Sep 2007 Preclinical development is ongoing